<DOC>
	<DOCNO>NCT01039701</DOCNO>
	<brief_summary>The primary purpose study determine safety tolerability AZD1446 v Placebo give add-on treatment Donepezil 4 week patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>4 Week , Safety Tolerability Study Patients With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>history progressive worsen memory cognitive function least 12 month treatment stable dose donepezil ( 10 mg ) least 3 month patient appropriate caregiver , require study visit history allergy/hypersensitivity reaction significant neurological disease dementia Alzheimer 's disease myocardial infarction acute coronary syndrome within last year</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>mild moderate Alzheimer 's disease</keyword>
	<keyword>To determine safety tolerability AZD1446 v Placebo give add-on treatment Donepezil patient mild moderate Alzheimer 's disease</keyword>
</DOC>